Literature DB >> 33183679

COVID-19 and the health of people who use drugs: What is and what could be?

Jason Grebely1, Magdalena Cerdá2, Tim Rhodes3.   

Abstract

SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know it, and continues to do so. How COVID-19 affects people who use drugs, the environments in which they live, and capacities of response, warrants immediate attention. This special issue begins to map how COVID-19 is altering the health of people who use drugs, including in relation to patterns of drug use, service responses, harms that may relate to drug use, interventions to reduce risk of harms, COVID-19 health, and drug policies. We emphasise the need to envisage COVID-19 and its effects as a matter of intersecting 'complex adaptive systems': that is, the impacts of COVID-19 extend beyond the virus and related illness conditions to encompass multiple social, cultural, economic, policy and political effects; and these affect the health of people who use drugs directly as well as indirectly by altering the risk and enabling environments in which they live. We synthesize emergent evidence on the impact of COVID-19 on the health of people who use drugs. A key concern we identify is how to sustain policy and service delivery improvements prompted by COVID-19. We need to maintain an ethos of emergent adaptation and experimentation towards the creation of safer environments in relation to the health of people who use drugs.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug users; Harm reduction; Injecting; PWID; SARS-CoV-2; Treatment

Mesh:

Year:  2020        PMID: 33183679     DOI: 10.1016/j.drugpo.2020.102958

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  21 in total

1.  COVID-19 economic impact payments and opioid overdose deaths: A response.

Authors:  Jon E Sprague; Arthur B Yeh; Qizhen Lan; Jamie Vieson; Maggie McCorkle
Journal:  Int J Drug Policy       Date:  2022-06-16

2.  Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population-based, community intervention trial.

Authors:  Brandon D L Marshall; Nicole Alexander-Scott; Jesse L Yedinak; Benjamin D Hallowell; William C Goedel; Bennett Allen; Robert C Schell; Yu Li; Maxwell S Krieger; Claire Pratty; Jennifer Ahern; Daniel B Neill; Magdalena Cerdá
Journal:  Addiction       Date:  2021-11-29       Impact factor: 6.526

3.  Factors associated with 60-day adherence to "safer supply" opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency.

Authors:  Marion Selfridge; Kiffer Card; Taylor Kandler; Erin Flanagan; Emily Lerhe; Ash Heaslip; Anne Nguyen; Matthew Moher; Bernie Pauly; Karen Urbanoski; Chris Fraser
Journal:  Int J Drug Policy       Date:  2022-05-04

4.  The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals.

Authors:  Colleen B Mistler; Christine M Curley; Aviana O Rosen; Renee El-Krab; Jeffrey A Wickersham; Michael M Copenhaver; Antoine Khati; Roman Shrestha
Journal:  J Community Health       Date:  2021-03-26

5.  COVID-19 Impact on Healthcare and Supportive Services for People Who Use Drugs (PWUDs) in Malaysia.

Authors:  Balasingam Vicknasingam; Nur Afiqah Mohd Salleh; Weng-Tink Chooi; Darshan Singh; Norzarina Mohd Zaharim; Adeeba Kamarulzaman; Marek C Chawarski
Journal:  Front Psychiatry       Date:  2021-03-29       Impact factor: 4.157

6.  How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.

Authors:  Trang Thu Nguyen; Giang Thi Hoang; Duc Quang Nguyen; Anh Huu Nguyen; Ngoc Anh Luong; Didier Laureillard; Nicolas Nagot; Don Des Jarlais; Huong Thi Duong; Thanh Thi Tuyet Nham; Oanh Thi Hai Khuat; Khue Minh Pham; Mai Sao Le; Laurent Michel; Delphine Rapoud; Giang Minh Le
Journal:  Harm Reduct J       Date:  2022-01-29

7.  The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months.

Authors:  Alex S Bennett; Tarlise Townsend; Luther Elliott
Journal:  Int J Drug Policy       Date:  2021-12-01

8.  Covid-19 and child criminal exploitation in the UK: implications of the pandemic for county lines.

Authors:  Ben Brewster; Grace Robinson; Bernard W Silverman; Dave Walsh
Journal:  Trends Organ Crime       Date:  2021-12-06

9.  Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study.

Authors:  Jessica Markby; Sonjelle Shilton; Xiaohui Sem; Huan Keat Chan; Rosaida Md Said; Sasikala Siva; Zalwani Zainuddin; Norasiah Abu Bakar; Haniza Omar; Ryan Jose Iii Ruiz; Mary Gaeddert; Alexander Tyshkovskiy; Madeline Adee; Jagpreet Chhatwal; Suresh Kumar; Jean-Michel Piedagnel; Rozainanee Mohd Zain; Caroline Menétrey; Fazidah Yuswan; Nazrila Hairizan Nasir; Isabelle Andrieux-Meyer; Fatanah Ismail; Rozita Zakaria; Ruziaton Hasim; Shahnaz Murad; Philippa Easterbrook; Muhammad Radzi Abu Hassan
Journal:  BMJ Open       Date:  2021-12-24       Impact factor: 2.692

Review 10.  Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework.

Authors:  Tribesty Nguyen; Jane A Buxton
Journal:  Int J Drug Policy       Date:  2021-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.